Loading...
Loading...
Contributors:
Dataset URI:
10.3389/fonc.2026.1900671.s001BackgroundSerum free light chain (sFLC) testing is central to the diagnosis and monitoring of plasma cell disorders, but assay availability and implementation can vary by laboratory setting. We evaluated a domestic latex-enhanced immunoturbidimetric Kehua serum sFLC assay against Freelite and N Latex systems.MethodsResidual serum samples from 133 adults with suspected or established monoclonal gammopathies were measured in parallel by Kehua and Freelite; 122 were also tested by N Latex. Precision was assessed with low- and high-level serum controls. Method agreement was evaluated using correlation, Passing-Bablok regression, Bland-Altman analysis, qualitative concordance and comparator-defined ROC analysis.ResultsKehua within-run CVs were ConclusionThe Kehua serum assay demonstrated acceptable precision and good clinical agreement with two imported methods. It may serve as a domestic option for routine serum sFLC quantification, provided method-specific intervals are maintained and the same platform is used for serial monitoring.
Keyword(s):
immunoassay; immunoglobulin light chains; multiple myeloma; Oncology and Carcinogenesis not elsewhere classified; paraproteinemias.
MeSH Term(s):
Grants and Funding:
No Grants or Funding Data Available
Associated Publication(s):
Supplementary Data:
No Supplementary Data Available
Related Dataset(s):
No Related Dataset Data Available
The National Library of Medicine (NLM) provides information about biomedical datasets. Inclusion on an NLM Web page does not imply endorsement of, or agreement with, the contents by NLM or the National Institutes of Health. Learn more: NLM Web Policies (nih.gov)